HB Wealth Management’s Kura Oncology KURA Stock Holding History

HB Wealth Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$167K	Buy	+15,593	New	+$174K	﹤0.01%	1754

Other funds holding KURA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

HB Wealth Management's KURA Position: Q3 2026 in Review

HB Wealth Management opened a new position in Kura Oncology (KURA) in Q3 2026: 15,593 shares worth $167K. The stake represents ﹤0.01% of the portfolio and ranks #1754 among its holdings.

28 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

HB Wealth Management held 15,593 shares of Kura Oncology worth $167K as of Q3 2026.
Kura Oncology was a new HB Wealth Management position in Q3 2026.
Kura Oncology made up ﹤0.01% of HB Wealth Management's portfolio in Q3 2026, its #1754 holding.
28 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on HB Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.